Hematopoietic stem cell transplantation for Hodgkin's disease

por Patah, Poliana, Fayad, Luis, de Lima, Marcos
Publicado 2011

Nuclear Translocation of B-Cell-Specific Transcription Factor, BACH2, Modulates ROS Mediated Cytotoxic Responses in Mantle Cell Lymphoma

por Chen, Zheng, Pittman, Eric F., Romaguera, Jorge, Fayad, Luis, Wang, Michael, Neelapu, Sattva S., Mclaughlin, Peter, Kwak, Larry, McCarty, Nami
Publicado 2013

Targeting Wnt pathway in mantle cell lymphoma-initiating cells

por Mathur, Rohit, Sehgal, Lalit, Braun, Frank K., Berkova, Zuzana, Romaguerra, Jorge, Wang, Michael, Rodriguez, M. Alma, Fayad, Luis, Neelapu, Sattva S., Samaniego, Felipe
Publicado 2015

(18)F-Fluorothymidine PET is an early and superior predictor of progression-free survival following chemoimmunotherapy of diffuse large B cell lymphoma: a multicenter study

por Minamimoto, Ryogo, Fayad, Luis, Vose, Julie, Meza, Jane, Advani, Ranjana, Hankins, Jordan, Mottaghy, Felix, Macapinlac, Homer, Heinzel, Alexander, Juweid, Malik E., Quon, Andrew
Publicado 2021

Impact of histologic subtypes and treatment modality among patients with primary central nervous system lymphoma: a SEER database analysis

por Chihara, Dai, Fowler, Nathan H., Oki, Yasuhiro, Fanale, Michelle A., Nastoupil, Loretta J., Westin, Jason R., Fayad, Luis E., Neelapu, Sattva S., Cheah, Chan Yoon
Publicado 2018

A phase 2, open-label, multicenter study of the long-term safety of siltuximab (an anti-interleukin-6 monoclonal antibody) in patients with multicentric Castleman disease

por van Rhee, Frits, Casper, Corey, Voorhees, Peter M., Fayad, Luis E., van de Velde, Helgi, Vermeulen, Jessica, Qin, Xiang, Qi, Ming, Tromp, Brenda, Kurzrock, Razelle
Publicado 2015

P1092: A PHASE II INVESTIGATOR INITIATED STUDY OF ACALABRUTINIB, LENALIDOMIDE AND RITUXIMAB (AR2) IN PATIENTS WITH PREVIOUSLY UNTREATED HIGH TUMOR BURDEN FOLLICULAR LYMPHOMA

por Strati, Paolo, Feng, Lei, Westin, Jason, Nair, Ranjit, Gouni, Sushanth, Fayad, Luis, Rodriguez, Maria, Chihara, Dai, Malpica, Luis, Steiner, Raphael, Gallardo, Mariana, Nastoupil, Loretta J., Neelapu, Sattva
Publicado 2023

Diffuse large B-cell lymphoma in very elderly patients over 80 years old: Incorporating consolidative radiation therapy into management decisions

por Pinnix, Chelsea C., Andraos, Therese Y., Dabaja, Bouthaina, Milgrom, Sarah, Smith, Grace, Chihara, Dai, Ng, Andrea, Fayad, Luis E., Oki, Yasuhiro, Neelapu, Sattva, Westin, Jason, Rodriguez, M. Alma, Nastoupil, Loretta J.
Publicado 2017

Pre-treatment maximum standardized uptake value predicts outcome after frontline therapy in patients with advanced stage follicular lymphoma

por Strati, Paolo, Ahmed, Mohamed Amin, Fowler, Nathan H., Nastoupil, Loretta J., Samaniego, Felipe, Fayad, Luis E., Hagemeister, Fredrick B., Romaguera, Jorge E., Rodriguez, Alma, Wang, Michael, Westin, Jason R., Cheah, Chan, Noorani, Mansoor, Feng, Lei, Davis, Richard E., Neelapu, Sattva S.
Publicado 2020

Lenalidomide plus rituximab (R(2)) in previously untreated marginal zone lymphoma: subgroup analysis and long‐term follow‐up of an open‐label phase 2 trial

por Becnel, Melody R., Nastoupil, Loretta J., Samaniego, Felipe, Davis, Richard E., You, M. J., Green, Michael, Hagemeister, Fredrick B., Fanale, Michelle A., Fayad, Luis E., Westin, Jason R., Wang, Michael, Oki, Yasuhiro, Forbes, Sheryl G., Feng, Lei, Neelapu, Sattva S., Fowler, Nathan H.
Publicado 2019

Response-adapted radiation therapy for newly diagnosed primary diffuse large B-cell lymphoma of the CNS treated with methotrexate-based systemic therapy

por Sheu, Tommy, Milgrom, Sarah A., Andraos, Therese Y., Gunther, Jillian R., Chi, Linda, Nastoupil, Loretta, Fowler, Nathan, Oki, Yasuhiro, Fanale, Michelle A., Fayad, Luis E., Hagemeister, Fredrick, Neelapu, Sattva S., Medeiros, L. Jeffrey, Hosing, Chitra, Nieto, Yago, Ahmed, Sairah, Alousi, Amin M., Dabaja, Bouthaina, Pinnix, Chelsea C.
Publicado 2018

Hematopoietic recovery and immune reconstitution after axicabtagene ciloleucel in patients with large B-cell lymphoma

por Strati, Paolo, Varma, Ankur, Adkins, Sherry, Nastoupil, Loretta J., Westin, Jason R., Hagemeister, Fredrick B, Fowler, Nathan H, Lee, Hun J., Fayad, Luis E., Samaniego, Felipe, Ahmed, Sairah, Chen, Yiming, Horowitz, Sandra, Arafat, Sara, Johncy, Swapna, Kebriaei, Partow, Mulanovich, Victor Eduardo, Heredia, Ella Ariza, Neelapu, Sattva S.
Publicado 2020

The iR(2) regimen (ibrutinib plus lenalidomide and rituximab) for relapsed/refractory DLBCL: A multicentre, non-randomised, open-label phase 2 study

por Ramchandren, Radhakrishnan, Johnson, Peter, Ghosh, Nilanjan, Ruan, Jia, Ardeshna, Kirit M., Johnson, Roderick, Verhoef, Gregor, Cunningham, David, de Vos, Sven, Kassam, Shireen, Fayad, Luis, Radford, John, Bailly, Sarah, Offner, Fritz, Morgan, David, Munoz, Javier, Ping, Jerry, Szafer-Glusman, Edith, Eckert, Karl, Neuenburg, Jutta K., Goy, Andre
Publicado 2022

Axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma patients in complete metabolic response

por Jallouk, Andrew P., Gouni, Sushanth, Westin, Jason, Feng, Lei, Mistry, Haleigh, Steiner, Raphael E., James, Jinsu, Noorani, Mansoor, Horowitz, Sandra, Puebla-Osorio, Nahum, Fayad, Luis E., Iyer, Swaminathan P., Hawkins, Misha, Flowers, Christopher R., Ahmed, Sairah, Nastoupil, Lo retta J, Kebriaei, Partow, Shpall, Elizabeth J., Neelapu, Sattva S., Nieto, Yago, Strati, Paolo
Publicado 2022

The risk of central nervous system relapses in patients with peripheral T-cell lymphoma

por Chihara, Dai, Fanale, Michelle A., Miranda, Roberto N., Noorani, Mansoor, Westin, Jason R., Nastoupil, Loretta J., Hagemeister, Fredrick B., Fayad, Luis E., Romaguera, Jorge E., Samaniego, Felipe, Turturro, Francesco, Lee, Hun J., Neelapu, Sattva S., Rodriguez, M. Alma, Wang, Michael, Fowler, Nathan H., Davis, Richard E., Medeiros, L. Jeffrey, Oki, Yasuhiro
Publicado 2018

A phase 1/2 study of lenalidomide and obinutuzumab with CHOP for newly diagnosed DLBCL

por Cherng, Hua-Jay J., Alig, Stefan K., Oki, Yasuhiro, Nastoupil, Loretta J., Fayad, Luis, Neelapu, Sattva S., Turturro, Francesco, Hagemeister, Fredrick, Craig, Alexander F. M., Macaulay, Charles W., Rodriguez, Maria Alma, Lee, Hun Ju, McDonnell, Timothy J., Flowers, Christopher R., Vega, Francisco, Green, Michael R., Feng, Lei, Kurtz, David M., Alizadeh, Ash A., Davis, R. Eric, Westin, Jason R.
Publicado 2022

Risk assessment with low-pass whole-genome sequencing of cell-free DNA before CD19 CAR T-cell therapy for large B-cell lymphoma

por Cherng, Hua-Jay J., Sun, Ryan, Sugg, Bryant, Irwin, Russell, Yang, Haopeng, Le, Cao Cuong, Deng, Qing, Fayad, Luis, Fowler, Nathan H., Parmar, Simrit, Steiner, Raphael, Hagemeister, Fredrick, Nair, Ranjit, Lee, Hun Ju, Rodriguez, Maria, Samaniego, Felipe, Iyer, Swaminathan P., Flowers, Christopher R., Wang, Linghua, Nastoupil, Loretta J., Neelapu, Sattva S., Ahmed, Sairah, Strati, Paolo, Green, Michael R., Westin, Jason
Publicado 2022

A phase 1 study of prophylactic anakinra to mitigate ICANS in patients with large B-cell lymphoma

por Strati, Paolo, Jallouk, Andrew, Deng, Qing, Li, Xubin, Feng, Lei, Sun, Ryan, Adkins, Sherry, Johncy, Swapna, Cain, Taylor, Steiner, Raphael E., Ahmed, Sairah, Chihara, Dai, Fayad, Luis E., Iyer, Swaminathan P., Horowitz, Sandra, Nastoupil, Loretta J., Nair, Ranjit, Hassan, Ahmed, Daoud, Taher E., Hawkins, Misha, Rodriguez, Maria A., Shpall, Elizabeth J., Ramdial, Jeremy L., Kebriaei, Partow, Hong, David S., Westin, Jason R., Neelapu, Sattva S., Green, Michael R.
Publicado 2023